Table 1 Baseline characteristics of study patients

 Number

46

 Age, years

63.7 ± 1.3

 Sex male,  %

71.7

 Body mass index, kg/m²

31.1 ± 0.7

 Waist, cm

105.4 ± 2.2

 HbA1c,  %

(mmol/mol)

7.6 ± 0.2

(60 ± 2)

Risk factors

 Smoking habit,  %

13.0

 Hypertension,  %

89.1

 Total cholesterol, mg/dl

165.3 ± 5.5

 HDL cholesterol, mg/dl

49.9 ± 2.2

 LDL cholesterol, mg/dl

91.6 ± 5.1

 Triglycerides, mg/dl

119.2 ± 8.5

 Albumin/creatinine ratio (mg/g)

129.5 ± 44.1

 Creatinine, mg/dl

1.11 ± 0.06

 eGFR, ml/min/1.73 mq

75.5 ± 3.9

Complications

 Retinopathy,  %

28.2

 Neuropathy,  %

17.9

 Coronary artery disease,  %

30.4

 Peripheral arterial disease,  %

21.7

 Cerebrovascular disease,  %

47.8

Medications

 Metformin,  %

65.2

 Sulphonylurea,  %

6.5

 Repaglinide,  %

4.3

 Pioglitazone,  %

6.5

 Insulin,  %

43.4

 ACE inhibitors/ARBs,  %

76.1

 Other anti-hypertensives,  %

78.2

 Statin,  %

80.4

 Anti-platelet agents,  %

56.5